ISPNO 2022 will be co-hosted by the University Medical Center Hamburg-Eppendorf with its Department of Pediatric Hematology and Oncology being one of the largest units of its kind in Germany, and the German Cancer Research Center (DKFZ) Heidelberg, the largest biomedical research institute in Germany, which, together with Heidelberg University Hospital, serves as mother institution for the Hopp Children's Cancer Center (KiTZ) Heidelberg.
The scientific program for ISPNO 2022 covers all areas related to Pediatric Neurooncology. The program will include the most recent cutting-edge preclinical and clinical research from the fields of neurosurgery, neuroradiology, neuropathology, biology, radiotherapy, pediatric neuro-oncology, immunotherapy, late effects, rehabilitation, and nursing. We will also have state-of-the art symposia, interdisciplinary sessions and round tables on the most challenging and timely topics in the field of pediatric neurooncology.
ISPNO 2022 is planned as a flexible hybrid meeting with live attendance, and the SIOPE BTG as an in-person meeting. We are fully convinced, that these formats will ensure high participation numbers by multidisciplinary health-care professionals and scientists from all over the world.
The vibrant, dynamic, and maritime metropolis of Hamburg, the second largest city of Germany, is located in Northern Germany. With its international airport only 20 minutes from the city center, it is easy to approach. The venue of ISPNO 2022, the Congress Center Hamburg (CCH Hamburg), is situated in the heart of the city. The CCH Hamburg will be fully renovated by 2021, and will then be one of the largest and most advanced convention centers in Europe. A range of hotels in walking distance to the CCH Hamburg is available. In addition, the larger regions of Hamburg and Northern Germany offer many touristic attractions, and Berlin can be reached in less than 2 hours by train.
Register as soon as possible, to take advantage of the early registration rates.
CCH - Congress Center Hamburg
Share this page